InspireMD (NYSE:NSPR) Share Price Crosses Above 50-Day Moving Average – Here’s What Happened

Shares of InspireMD, Inc. (NYSE:NSPR – Get Free Report) passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $0.65 and traded as high as $0.6757. InspireMD shares last traded at $0.6579, with a volume of 530,399 shares.

InspireMD Stock Up 22.1%

The firm’s fifty day moving average price is $0.65 and its two-hundred day moving average price is $1.06. The stock has a market capitalization of $30.59 million, a PE ratio of -0.88 and a beta of 0.92.

Institutional Investors Weigh In On InspireMD

Large investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC purchased a new stake in InspireMD during the 1st quarter valued at $29,000. BlackRock Inc. bought a new position in shares of InspireMD during the 2nd quarter valued at $86,000. Parkman Healthcare Partners LLC purchased a new position in shares of InspireMD in the 2nd quarter worth $1,692,000. Finally, Nantahala Capital Management LLC purchased a new position in shares of InspireMD in the 2nd quarter worth $2,363,876. Institutional investors own 44.78% of the company’s stock.

About InspireMD

(Get Free Report)

InspireMD, Inc is a medical device company focused on developing and commercializing products for the treatment of carotid artery disease and the prevention of stroke. Its technology is designed to support minimally invasive procedures that restore blood flow in narrowed or blocked arteries while helping to reduce the risk of embolic debris reaching the brain.

The company’s principal product is the CGuard carotid embolic prevention system, which combines a self-expanding carotid stent with a proprietary microNet mesh intended to trap plaque and other debris against the arterial wall during and after carotid artery stenting.

Featured Stories

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.